Vaxess, GC Pharma partner to develop smart release patch for influenza vaccine
Vaxess gets exclusive rights to commercialise MIMIX Flu Smart Release Patch in the US and Europe, and GC…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Oct 19
Vaxess gets exclusive rights to commercialise MIMIX Flu Smart Release Patch in the US and Europe, and GC…
17 Oct 19
The Companion dual chamber reconstitution syringe (C-DCS) helps maintain separation of the drug product from the diluent during…
16 Oct 19
Treatment of advanced Parkinson’s disease (PD) remains challenging, with fluctuations in motor status often resulting in patients becoming…
16 Oct 19
Secuado transdermal system is claimed to be the first-and-only transdermal patch formulation to treat adults with schizophrenia
09 Oct 19
The most common side effects observed with eTNS use are: drowsiness, an increase in appetite, trouble sleeping, teeth…
07 Oct 19
Fasenra is the only respiratory biologic that can be administered at home or in a doctor’s office with…
04 Oct 19
Amneal’s generic Suboxone will come pre-packaged in disposable, secure and tamper-evident MedicaSafe cartridges
24 Sep 19
Trinity College scientists claim to have identified a protein linked to lower blood sugar levels that may help…
12 Sep 19
The collaboration offers a cost-effective and efficient non-narcotic therapy solution for post-operative pain management
11 Sep 19
The data confirms no significant difference in all-cause mortality for the Zilver PTX drug-eluting stent compared to traditional…